Opinion|Videos|November 30, 2023
Collaborating With Your Oncology Care Team to Manage Side Effects of HER2-Positive Metastatic Breast Cancer Treatment
Author(s)Sara M. Tolaney, MD, MPH
Patients with metastatic breast cancer receiving HER2-targeted therapies should promptly report any respiratory symptoms or signs of lung and heart disease to their oncology care team to facilitate early intervention and management of side effects.
Advertisement
Episodes in this series
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Inside the ‘Weird and Wacky’ Frontier of New Targeted Therapy for Lung Cancer
2
FDA Approves Imdelltra for Extensive-Stage Small Cell Lung Cancer
3
FDA Approves Hyrnuo in Some with Locally Advanced/Metastatic NSCLC
4
FDA Grants Fast Track Status to New Gastric Cancer Treatment
5
